Product Information
TAVABOROLE 5% TOPICAL SOLUTION is a generic product labeled by Viona Pharmaceuticals Inc., priced at $3.3901 per ML under NDC 72578010204. Its NADAC has been published 170 times since Jul 5, 2023.
FDA first approved this application on Apr 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
43.5 mg/mL
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578010204
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TAVABOROLEApproval Type
Generic (ANDA)
FDA Application
ANDA212294FDA Approved
4/10/2023
TE Code
AB
On Market Since
4/24/2023
Pharmacological Classes
Price Statistics
The NADAC for TAVABOROLE 5% TOPICAL SOLUTION has been published 170 times since Jul 5, 2023, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3901 per ML |
|---|---|
| All-time high | $5.3734 (Dec 13, 2023) |
| All-time low | $2.0377 (Jul 17, 2024) |
| 52-week high | $4.0999 |
| 52-week low | $3.3901 |
| Median price | $3.7190 |
| Average price | $3.8633 |
| Largest weekly change | +50.6% (Sep 18, 2024) |
| Weeks tracked | 170 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tavaborole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Oxaborole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAVABOROLE 5% TOPICAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TAVABOROLE 5% TOPICAL SOLUTION, manufactured by Viona Pharmaceuticals Inc., is $3.3901 per ML (NDC 72578010204), effective Sep 30, 2026.
How has the price of TAVABOROLE 5% TOPICAL SOLUTION changed over time?
Over the history we have for it, the NADAC for TAVABOROLE 5% TOPICAL SOLUTION has declined 36.9%. It has been tracked across 170 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for TAVABOROLE 5% TOPICAL SOLUTION?
Since Jul 5, 2023, the NADAC for TAVABOROLE 5% TOPICAL SOLUTION has ranged from a low of $2.0377 (Jul 17, 2024) to a high of $5.3734 (Dec 13, 2023), with a median of $3.7190 per ML.
Are there cheaper alternatives to TAVABOROLE 5% TOPICAL SOLUTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TAVABOROLE 5% TOPICAL SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures TAVABOROLE 5% TOPICAL SOLUTION?
TAVABOROLE 5% TOPICAL SOLUTION (NDC 72578010204) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.